Cohort Study | Assessment of Cystatin C level for cardiovascular and mortality risk stratification in adults with mild CKD.
1 Nov, 2022 | 11:56h | UTCCommentary: Cystatin C Is a Better Marker of Cardiovascular Risk in CKD – Renal & Urology News
Commentary on Twitter
#CystatinC-estimated GFR may help identify which patients with creatinine-estimated GFR of 45-59 are at high risk of future cardiovascular disease from their mild CKD. #OAResearch #OAWeek https://t.co/2U6NNPMPS2
— JAMA Network Open (@JAMANetworkOpen) October 28, 2022